Major Announcements

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) announced that its Dobutamine Hydrochloride Injection has received approval for registration.

China Biologic Products Holdings, Inc. (01177) announced that the new indication for the first-line treatment of squamous non-small cell lung cancer using Benmelstobart combined with chemotherapy, sequentially combined with Anlotinib, has been approved for marketing.

Shoucheng Holdings Limited (00697) announced an investment in the Huatai Sanxia New Energy REIT.

Guotai Junan International Holdings Limited (01788) has received a privatization proposal from Guotai Haitong Securities Co., Ltd. (02611) at a premium of approximately 44.2%. The company's shares are scheduled to resume trading on August 10.

Xunce Technology Co., Ltd. (03317) has signed a strategic cooperation memorandum with Tianhe Computing to jointly explore data infrastructure and energy token factory models under the convergence of AI and energy.

Lingbao Gold Group Company Ltd. (03330) reported significant progress in exploration work at its Xinjiang Habahe Huatai company, with the gold metal content (mineral resources) surging to 53.94 tonnes.

Bote Chewei (02889) plans to acquire 70% of the issued shares of Chengdu Mingyi Electronic Technology Co., Ltd. for a consideration not exceeding RMB 1.4 billion.

Chifeng Jilong Gold Mining Co., Ltd. (06693) announced the temporary suspension of operations at its Laos Mengkang rare earth project.

Zhejiang Shibao Company Limited (01057) plans to issue A-shares to raise no more than RMB 1.394 billion.

Operational Performance

AXERA (00600) released its interim results, reporting a substantial 181.8% increase in revenue to RMB 402 million. Both its edge AI and intelligent automotive businesses grew by over 250%.

Guanghe Technology Co., Ltd. (01989) published its interim results, with net profit attributable to shareholders reaching RMB 956 million, a year-on-year increase of 94.39%.

FIH Mobile Limited (02038) released its interim results, showing a profit attributable to shareholders of USD 9.306 million, a year-on-year increase of 50.95%.

Peijia Medical Limited (09996) expects its first-half revenue to be in the range of approximately RMB 415 million to RMB 435 million, representing a year-on-year increase of about 17.4% to 23.1%.

Tonking Gold Holdings Limited (00340) issued a profit alert, expecting net profit attributable to shareholders for the interim period to be approximately HKD 510 million to HKD 530 million, an increase of about 49% to 55% year-on-year.

West China Cement Limited (02233) issued a profit warning, anticipating a decrease in net profit attributable to shareholders for the first half of the year by approximately 45% to 50% year-on-year.

Longfor Group Holdings Limited (00960) reported total contracted sales of RMB 18.64 billion for the first seven months of the year.

China Longyuan Power Group Corporation Limited (00916) recorded cumulative power generation of approximately 44,975.7 GWh for the first seven months, a year-on-year decrease of 2.19%.

Yuexiu Property Company Limited (00123) achieved cumulative contracted sales of approximately RMB 55.608 billion for the first seven months.